Continued Versus Discontinued Oxytocin Stimulation of Labour

PHASE4CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Adverse Reaction to Oxytocin
Interventions
DRUG

Oxytocin

Both arms will initially receive routine treatment with oxytocin according to national guidelines. When active phase of labour is established both arms will have their infusion-set changed for a blinded infusion-set.

DRUG

Placebo

Both arms will initially receive routine treatment with oxytocin according to national guidelines. When active phase of labour is established both arms will have their infusion-set changed for a blinded infusion-set.

Trial Locations (10)

1105

Academic Medical Center, Amsterdam

6000

Sygehus LIllebælt, Kolding

8210

Aarhus University Hospital, Aarhus

8930

Department of Gynecology and Obstetrics, Randers

9000

Aalborg University Hospital, Aalborg

Unknown

Rigshospitalet, Copenhagen

Regionshospitalet Herning, Herning

Nordsjællandshospital, Hillerød

Hvidovre Hospital, Hvidovre

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Randers Regional Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Kolding Sygehus

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Herning Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

University of Amsterdam

OTHER

collaborator

Hillerod Hospital, Denmark

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT02553226 - Continued Versus Discontinued Oxytocin Stimulation of Labour | Biotech Hunter | Biotech Hunter